NRAS and hepatocellular carcinoma: Through the whole HCC cohort of patients, TP53 (19 of 41 patients, 46.3%), followed by CTNNB1 (10, 24.4%) and NRAS (2, 4.9%; Fig. 1), was the most conventional mutation gene in ctDNA from our HCC cases.